Bilastine is a white to off-white crystalline powder that is sparingly soluble in methylene chloride and practically insoluble in acetone. It has an assay range of 98.0% to 102.0%.

Products still subject to third-party patent protection might be available solely for R&D purposes.

Deferasirox, marketed under the brand Refarmed Chemicals, is a cornerstone in the treatment of chronic iron overload due to blood transfusions in conditions such as thalassemia and sickle cell disease. This condition, if not properly managed, can have severe consequences for organ function. Deferasirox is available in oral tablet form, with strengths of 250 mg, 500 mg, and 1000 mg, allowing for flexibility and precision in dosing to meet individual patient needs. Crafted as an iron chelator, Deferasirox plays a crucial role in binding excess iron within the body and facilitating its excretion through urine. This targeted mechanism asserts its importance in maintaining a healthy balance of iron and preventing the potential toxicity associated with overload. Patients are advised to take Deferasirox with or without food, adhering to a dosing schedule that is tailored to their specific iron levels and bodily response, underscoring the need for a personalized approach to treatment. Regarding its physical properties, Deferasirox appears as a white to pale yellowish crystalline powder, primarily soluble in DMF (Dimethylformamide) and slightly soluble in methanol. These characteristics are essential for ensuring its effectiveness and stability as a pharmaceutical agent. It is imperative that patients undergo regular blood tests and health monitoring for optimum results and to prevent adverse effects such as gastrointestinal distress, skin reactions, and potential liver or renal impairment. Additionally, care must be taken in cases of known hypersensitivity to Deferasirox or pre-existing severe renal or liver conditions. Our documentation and certifications like Good Manufacturing Practice (GMP) and the Drug Master File (DMF) guarantee the highest levels of quality and compliance with industry standards. It is our priority to ensure that this crucial pharmaceutical material is of the utmost purity and efficacy, as reflected in our stringent quality control parameters including the presence of residual solvents and related substances, all documented for your assurance. Please note that while Deferasirox is a vital medication for many patients, it requires diligent medical supervision. Always consult healthcare professionals for specific medical advice and treatment instructions tailored to individual health profiles.

Products still subject to third-party patent protection might be available solely for R&D purposes.

**Product Overview: Febuxostat – A Robust Solution for Gout Management** Refarmed Chemicals presents Febuxostat, a meticulously prepared medication aimed at alleviating the pain and discomfort associated with gout. Made from a refined white powder, Febuxostat stands out in the pharmaceutical industry as a Xanthine Oxidase Inhibitor, crucial for managing hyperuricemia and recurrent gout attacks. Structured to meet corporate expectations, Febuxostat is a testament to Refarmed Chemicals' 30-year expertise in delivering quality generic and branded medications. Manufactured in compliance with strict guidelines, including the Drug Master File (DMF) and certifications such as WC and GMP, this product is a model of reliability and efficacy. Febuxostat's fundamental use is to decrease blood uric acid levels, offering those afflicted with gout a pathway to recovery by preventing acute flare-ups, and mitigating inflammation and pain in the joints. As a white, soluble powder, Febuxostat is highly soluble in DMSO and slightly soluble in methanol and water, simplifying its integration into diverse medical formulations. Clinical trials have informed a standard starting dosage of 40 mg, adjustable up to 80 mg based on individual patient requirements and the severity of symptoms. In its commitment to patient welfare, Refarmed Chemicals underlines potential side effects ranging from nausea and headaches to rashes, ensuring informed usage of Febuxostat. In alignment with our promise of transparency and safety, we advise consulting healthcare professionals for precise diagnotics and treatment plans. Furthermore, users should be attentive to contraindications, noting that Febuxostat is unsuitable for patients with severe liver or kidney disease, or for women who are pregnant or breastfeeding. Refarmed Chemicals' Febuxostat exceeds industry standards with its impressive assay value of 98.0% - 102.0% purity and a precise control of impurities, ensuring that the product meets stringent quality criteria. The company's analytical rigor is reflected in the detailed specification of residual solvents such as Acetone, Ethanol, and Isopropanol. In the journey to deliver improved health outcomes, Refarmed Chemicals' Febuxostat is more than just a medication; it symbolizes our dedication to quality, safety, and corporate responsibility in the global pharmaceutical landscape. [*Note: Product image depicts a detailed specification chart for Febuxostat, reiterating its quality and compositions.*]

Products still subject to third-party patent protection might be available solely for R&D purposes.

Nadifloxacin: Advanced Antibacterial Solution Refarmed Chemicals presents Nadifloxacin, an efficacious fluoroquinolone antibiotic designed for the assured treatment of various bacterial infections. With its potent broad-spectrum activity, Nadifloxacin offers healthcare professionals a robust option for combating Gram-negative and Gram-positive bacteria, that are often responsible for conditions such as urinary tract infections (UTIs), skin and soft tissue infections, respiratory tract infections, and certain sexually transmitted infections (STIs). Nadifloxacin's pharmacological profile indicates it is generally administered orally via tablets or suspension, with dosing regimens from 500-1000 mg every 12 hours, though this may adjust based on infection severity and individual patient requirements. This medication underscores its commitment to quality and safety, presenting a product that is white to yellowish in crystalline powder form, ensuring high purity with an assay value of ≥ 99.0%. Made with stringent adherence to Good Manufacturing Practice (GMP) standards, Nadifloxacin is both soluble and stable in various solvents, including sodium hydroxide TS and N,N-dimethylformamide (DMF), offering versatile formulation options. Its melting point ranges from 246-250°C, emphasizing its stability under a broad spectrum of conditions. Clarity and color of the solution are maintained as clear, colorless to slight yellow, with stringent checks on impurities – including heavy metals and arsenics kept to minimum levels, aligning with industry standards. While side effects can include nausea, vomiting, diarrhea, and other conditions, they are closely monitored, ensuring optimal patient safety. Patients with hypersensitivity, seizure histories, or on interfering medications are advised to avoid this product and consult healthcare professionals. Nadifloxacin's efficacy is matched only by Refarmed Chemicals' attention to detail and commitment to patient health. With transparent documentation and certification, consumers are assured of the product's integrity, supplemented by the comprehensive information provided by the DKSH Group to facilitate informed decision-making. As a corporate customer looking to source reliable antibiotics, Nadifloxacin represents a high-grade pharmaceutical ingredient that stands for efficacy and safety in the management of bacterial infections.

Products still subject to third-party patent protection might be available solely for R&D purposes.